Bispecific Antibodies: From Research to Clinical Application.

作者: Junjie Shen , Wenxu Zhao , Cheng Qian , Yanan Qi , Jiabing Ma

DOI: 10.3389/FIMMU.2021.626616

关键词:

摘要: Bispecific antibodies (BsAbs) are with two binding sites directed at different antigens or epitopes on the same antigen. The clinical therapeutic effects of BsAbs superior to those monoclonal (MoAbs), broad applications for tumor immunotherapy as well treatment other diseases. Recently, progress in antibody protein engineering and recombinant DNA technology, various platforms generating types based novel strategies, uses, have been established. More than 30 mature commercial technology used create develop heterologous recombination heavy chains matching light chains. detailed mechanisms clinical/therapeutic action demonstrated these BsAbs. Three kinds received market approval, more 110 stages trials. In this paper, we elaborate classic platforms, mechanisms, We hope that review can stimulate new ideas development improve current strategies.

参考文章(187)
Toshiyuki Takai, Roles of Fc receptors in autoimmunity Nature Reviews Immunology. ,vol. 2, pp. 580- 592 ,(2002) , 10.1038/NRI856
Xiufeng Wu, Arlene J Sereno, Flora Huang, Steven M Lewis, Ricky L Lieu, Caroline Weldon, Carina Torres, Cody Fine, Micheal A Batt, Jonathan R Fitchett, Andrew L Glasebrook, Brian Kuhlman, Stephen J Demarest, Fab-based bispecific antibody formats with robust biophysical properties and biological activity. mAbs. ,vol. 7, pp. 470- 482 ,(2015) , 10.1080/19420862.2015.1022694
Marianne Schiffer, Karl D. Hardman, Mical K. Wood, Allen B. Edmundson, Madonna E. Hook, Kathryn R. Ely, Harold F. Deutsch, A Preliminary Crystallographic Investigation of a Human l-Type Bence-Jones Protein Journal of Biological Chemistry. ,vol. 245, pp. 728- 730 ,(1970) , 10.1016/S0021-9258(18)63324-1
Maarten Van Roy, Cedric Ververken, Els Beirnaert, Sven Hoefman, Joost Kolkman, Michel Vierboom, Elia Breedveld, Bert ‘t Hart, Sofie Poelmans, Lieselot Bontinck, Alex Hemeryck, Sandy Jacobs, Judith Baumeister, Hans Ulrichts, The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis Arthritis Research & Therapy. ,vol. 17, pp. 135- 135 ,(2015) , 10.1186/S13075-015-0651-0
Uwe Reusch, Johannes Duell, Kristina Ellwanger, Carmen Herbrecht, Stefan HJ Knackmuss, Ivica Fucek, Markus Eser, Fionnuala McAleese, Vera Molkenthin, Fabrice Le Gall, Max Topp, Melvyn Little, Eugene A Zhukovsky, A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19+ tumor cells mAbs. ,vol. 7, pp. 584- 604 ,(2015) , 10.1080/19420862.2015.1029216
Max S. Topp, Nicola Gökbuget, Gerhard Zugmaier, Petra Klappers, Matthias Stelljes, Svenja Neumann, Andreas Viardot, Reinhard Marks, Helmut Diedrich, Christoph Faul, Albrecht Reichle, Heinz-August Horst, Monika Brüggemann, Dorothea Wessiepe, Chris Holland, Shilpa Alekar, Noemi Mergen, Hermann Einsele, Dieter Hoelzer, Ralf C. Bargou, Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia Journal of Clinical Oncology. ,vol. 32, pp. 4134- 4140 ,(2014) , 10.1200/JCO.2014.56.3247
Klementina Fon Tacer, Angie L. Bookout, Xunshan Ding, Hiroshi Kurosu, George B. John, Lei Wang, Regina Goetz, Moosa Mohammadi, Makoto Kuro-o, David J. Mangelsdorf, Steven A. Kliewer, Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse Molecular Endocrinology. ,vol. 24, pp. 2050- 2064 ,(2010) , 10.1210/ME.2010-0142
Takehisa Kitazawa, Tomoyuki Igawa, Zenjiro Sampei, Atsushi Muto, Tetsuo Kojima, Tetsuhiro Soeda, Kazutaka Yoshihashi, Yukiko Okuyama-Nishida, Hiroyuki Saito, Hiroyuki Tsunoda, Tsukasa Suzuki, Hideki Adachi, Taro Miyazaki, Shinya Ishii, Mika Kamata-Sakurai, Takeo Iida, Aya Harada, Keiko Esaki, Miho Funaki, Chifumi Moriyama, Eriko Tanaka, Yasufumi Kikuchi, Tetsuya Wakabayashi, Manabu Wada, Masaaki Goto, Takeshi Toyoda, Atsunori Ueyama, Sachiyo Suzuki, Kenta Haraya, Tatsuhiko Tachibana, Yoshiki Kawabe, Midori Shima, Akira Yoshioka, Kunihiro Hattori, A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model Nature Medicine. ,vol. 18, pp. 1570- 1574 ,(2012) , 10.1038/NM.2942
Yiren Xu, John Lee, Cuong Tran, Tyler H Heibeck, Willie D Wang, Junhao Yang, Ryan L Stafford, Alexander R Steiner, Aaron K Sato, Trevor J Hallam, Gang Yin, Production of bispecific antibodies in "knobs-into-holes" using a cell-free expression system. mAbs. ,vol. 7, pp. 231- 242 ,(2015) , 10.4161/19420862.2015.989013
Aran F Labrijn, Joyce I Meesters, Patrick Priem, Rob N de Jong, Ewald T J van den Bremer, Muriel D van Kampen, Arnout F Gerritsen, Janine Schuurman, Paul W H I Parren, Controlled Fab-arm exchange for the generation of stable bispecific IgG1 Nature Protocols. ,vol. 9, pp. 2450- 2463 ,(2014) , 10.1038/NPROT.2014.169